Identification of prognostic biomarker of non-small cell lung cancer based on mitochondrial permeability transition-driven necrosis-related genes and determination of anti-tumor effect of ARL14
We first performed the comprehensive analysis of MPTDN in NSCLC and screened three NSCLC-related biomarkers as promising biomarkers. ARL14 might be a new potential target for therapy of NSCLC.
Authors
- Xiaokang Shen (ORCID: https://orcid.org/0000-0002-7083-6693)
- Aiping Zhang (ORCID: https://orcid.org/0000-0002-6367-9554)
- Zheng Lin (ORCID: https://orcid.org/0000-0003-2357-0535)
- Wen Chen (ORCID: https://orcid.org/0000-0001-7017-6990)
- Zhifei Ma (ORCID: https://orcid.org/0000-0001-7066-2964)
Institutions
- Nanjing Medical University (CN)
Publication Details
- Journal
- Hereditas
- Published
- 2025-02-03
- DOI
- https://doi.org/10.1186/s41065-025-00379-7
- Citations
- 1
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.81